(Reuters) – Bristol Myers Squibb Co said on Wednesday it had transferred its commercial operations in Russia to a third-party distributor and incurred $39 million in related costs.
The drugmaker said in a filing that its remaining assets in the country were not material. (https://bit.ly/3PRxn5G)
(Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)